TE_138

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family MIR
TE superfamily L2-end
TE class SINE
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 0.44
Counts of samples TCGA_tumor:442; TCGA_normal:23; GTEx:1113
TSS chr1(-):15487113



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_138.1 - Intergenic Non-coding Non-coding chr1(-):15464852,15464872,15467140,15467290,15484502,15484774,15487046,15487114
teRNA_138.2 - Intergenic Non-coding Non-coding chr1(-):15472398,15472418,15484502,15484774,15487046,15487114
teRNA_138.3 - Intergenic Non-coding Non-coding chr1(-):15484519,15484539,15484625,15484774,15487046,15487114
teRNA_138.4 - Intergenic Non-coding Non-coding chr1(-):15484030,15484050,15484502,15484774,15487046,15487114
teRNA_138.5 - Intergenic Non-coding Non-coding chr1(-):15464852,15464872,15486488,15486623,15487046,15487114


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).